SARS (Severe Acute Respiratory Syndrome) is a type of acute respiratory syndrome. Coronavirus-2 (SARS-CoV-2) is the virus that causes COVID-19, which has spread globally. However, there is no precise drug that can prevent or treat COVID-19 at this time. Researchers from all over the world are striving to find the most effective ways to treat and prevent COVID-19, from repurposing existing medications to developing novel antiviral therapies. A list of repurposed drugs with significant pharmacological effects and therapeutic efficacies in treating COVID-19 patients might be developed, according to fresh research and clinical data on the virologic SARS-CoV-2.
Title : Microemulsion based in situ gel of erythromycin for ocular ailments
Dasharath Muljibhai Patel, Graduate School of Pharmacy, India
Title : Nanomaterial-mediated systemically administered m-RNA-based gene therapy directed exclusively to cancer, present successes and future prospects
A C Matin, Stanford University, United States
Title : Thymoquinone-induced cellular and mitochondrial health in hepatocellular and cholangiocellular carcinoma
Consolato M Sergi, University of Ottawa, Canada
Title : Points to consider for the manufacturing of cell and gene therapies
Richard Denk, SKAN AG, Switzerland
Title : Pharmacological features of sparsentan, a novel dual endothelin and angiotensin receptor antagonist
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Development and validation of RP-HPLC method for the dissolution study of tofacitinib in pharmaceutical solid dosage form
Narapereddy Krishna Prasad, Reckitt Benckiser LLC, United States
Title : Does erector spinae plane block improve respiratory outcomes in adults with rib fractures?
Katie Aldred, University of Liverpool, United Kingdom
Title : Interdisciplinary perspective towards therapeutic potential in antenatal care
Anita, DMIHER, India
Title : Augmented anti-atopic dermatitis effect of crisaborole nanoemulgel in 2,4-Di-nitrochlorobenzene induced (DNCB) atopic dermatitis (AD) in Balb/c mice
Dipti Srivastava, Hygia institute of pharmaceutical education and research, India
Title : Formulation, characterization and evaluation: Micellar loaded complex of cuminum cyminum to treat causing disease of COVID 19 (Respiratory Infection)
Rudra Pratap Singh Rajput, Royal College of Pharmacy, India